Novartis psoriasis drug superior to Enbrel in study
ZURICH (Reuters) - Novartis psoriasis drug secukinumab was superior to Amgen's Enbrel in a late-stage study, the Swiss company said on Monday, putting...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/iZFvbhS901s/story01.htm
No comments:
Post a Comment